Pharvaris PHVS
NASDAQ PHVS
$35.25 -0.41 (-1.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Pharvaris (PHVS) Change in Cash (2020 - 2026)

Pharvaris' (PHVS) quarterly Change in Cash came in at -$57.2 million in Q1 2026, down 40.55% YoY from -$96.3 million in Q1 2025, and down 30.46% on a QoQ basis from -$43.9 million in Q4 2025.

Analysis

Pharvaris (PHVS) Change in Cash (2020 - 2026) Analysis & Trends

Pharvaris (PHVS) has 7 years of Change in Cash data on file, last reported at -$57.2 million in Q1 2026.

  • Quarterly Change in Cash fell 40.55% year-over-year to -$57.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.6 million (up 111.65% YoY) and the FY2025 annual result came in at $26.4 million, up 120.67% from the prior year.
  • Change in Cash retreated to -$57.2 million in Q1 2026, from -$43.9 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $19647.1 billion in Q2 2023 to a low of -$19641.1 billion in Q3 2023.
  • A 5-year average of $356.6 million and a median of -$27.1 million in 2023 frame the typical range for Change in Cash.
  • The widest YoY moves for Change in Cash: up 385414451.59% in 2023, down 127777546.09% in 2023.
  • Tracing PHVS's Change in Cash over 5 years: stood at -$21.0 million in 2022, then surged by 1318.07% to $256.0 million in 2023, then sank by 114.42% to -$36.9 million in 2024, then dropped by 18.81% to -$43.9 million in 2025, then tumbled by 30.46% to -$57.2 million in 2026.
  • The last three Change in Cash figures came in at -$57.2 million (Q1 2026), -$43.9 million (Q4 2025), and $151.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 Pharvaris 2.10 Bn 1.73 Bn 85,072.10 79.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79.09 Mn
Mar 31, 2026 -57.23 Mn
Dec 31, 2025 -43.86 Mn
Sep 30, 2025 151.68 Mn
Jun 30, 2025 -33.94 Mn
Mar 31, 2025 -40.72 Mn
Dec 31, 2024 -36.92 Mn
Sep 30, 2024 55,863.43 Bn
Jun 30, 2024 -54,778.40 Bn
Mar 31, 2024 -25.49 Mn
Dec 31, 2023 255.96 Mn
Sep 30, 2023 -19,641.07 Bn
Jun 30, 2023 19,647.11 Bn
Mar 31, 2023 -27.13 Mn
Dec 31, 2022 -21.01 Mn
Sep 30, 2022 22,983.57 Bn
Jun 30, 2022 -24,323.54 Bn
Mar 31, 2022 -20.22 Mn
Dec 31, 2021 -15.09 Mn
Sep 30, 2021 -11.89 Mn